
Christopher Schmid
· Professor of BiostatisticsBrown University · Biostatistics
Active 1961–2026
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
Christopher H. Schmid, PhD, is a Professor of Biostatistics and a former Chair of the Department of Biostatistics at Brown University. He is a founding member of the Center for Evidence Synthesis in Health at the Brown School of Public Health. His research focuses on methods and applications for meta-analysis, particularly Bayesian methods and software, as well as predictive models derived from combining data from different sources. He has a special interest in clinical trials, including N-of-1 trials and single-person multiple crossover studies, and has published extensively on meta-regression, multivariate methods, network meta-analysis, and the integration of N-of-1 studies. Dr. Schmid has contributed to the development of national standards for systematic reviews through the Institute of Medicine and has collaborated with medical and public health scientists on numerous applications. He holds a PhD in Statistics from Harvard University and a BA in Mathematics from Haverford College. Prior to his current position, he was on the faculty at Tufts University School of Medicine, where he served as Director of the Biostatistics Research Center and as Associate Director of the Clinical and Translational Science program.
Research topics
- Medicine
- Computer Science
- Applied psychology
- Medical physics
- Traditional medicine
- Genetics
- Environmental health
- Surgery
- Botany
- Biology
Selected publications
Canadian Medical Association Journal · 2020 · 693 citations
BACKGROUND: Most randomized controlled trials (RCTs) and meta-analyses of RCTs examine effect modification (also called a subgroup effect or interaction), in which the effect of an intervention varies by another variable (e.g., age or disease severity). Assessing the credibility of an apparent effect modification presents challenges; therefore, we developed the Instrument for assessing the Credibility of Effect Modification Analyses (ICEMAN). METHODS: To develop ICEMAN, we established a detailed…
JAMA Network Open · 2020 · 106 citations
Importance: Fourth-generation nicotine salt pod system (NSPS) electronic cigarettes (e-cigarettes) are the leading class of e-cigarettes. They contain high nicotine concentrations, which may facilitate switching among smokers, but could also lead to increased exposure to nicotine and biomarkers of potential harm. African American and Latinx smokers experience significant tobacco-related health disparities. The potential of NSPS e-cigarettes to reduce smoking-related harm among these groups is un…
Pay-for-Performance Incentives for Home Dialysis Use and Kidney Transplant
JAMA Health Forum · 2024-06-30 · 16 citations
articleOpen accessImportance: The Centers for Medicare & Medicaid Services' mandatory End-Stage Renal Disease Treatment Choices (ETC) model, launched on January 1, 2021, randomly assigned approximately 30% of US dialysis facilities and managing clinicians to financial incentives to increase the use of home dialysis and kidney transplant. Objective: To assess the ETC's association with use of home dialysis and kidney transplant during the model's first 2 years and examine changes in these outcomes by race, ethnici…
The Lancet Global Health · 2023-09-27 · 13 citations
articleOpen accessBackgroundDespite the importance of accurate and rapid assessment of hydration status in patients with acute diarrhoea, no validated tools exist to help clinicians assess dehydration severity in older children and adults. The aim of this study is to validate a clinical decision support tool (CDST) and a simplified score for dehydration severity in older children and adults with acute diarrhoea (both developed during the NIRUDAK study) and compare their accuracy and reliability with current WHO g…
JAIDS Journal of Acquired Immune Deficiency Syndromes · 2024-04-22 · 3 citations
articleOpen accessBACKGROUND: Pre-exposure prophylaxis (PrEP) is an effective approach to preventing HIV acquisition and recommended for populations over-represented in carceral systems, given the overlap with populations disproportionately impacted by HIV. However, few studies have focused on PrEP initiation outcomes in a carceral setting to maximize public health impact. SETTING: This study was conducted in a unified jail/prison system within the state of Rhode Island located in the United States. METHODS: A pr…
Recent grants
NIH · $422k · 1998
NIH · $1.2M · 2006
NIH · $698k · 2002
Frequent coauthors
- 315 shared
Issa J Dahabreh
- 302 shared
John P. A. Ioannidis
Stanford University
- 256 shared
Xin Sun
West China Hospital of Sichuan University
- 256 shared
Ravi Varadhan
- 256 shared
Geert J. M. G. van der Heijden
University of Amsterdam
- 256 shared
Joel Gagnier
Western University
- 256 shared
Stefan Schandelmaier
University of Basel
- 256 shared
Rodney A. Hayward
VA Center for Clinical Management Research
Education
- 1991
Ph.D.
Harvard University
- 1983
B.A.
Haverford College
Awards & honors
- Fellow of the American Statistical Association (ASA)
- Elected member of the Society for Research Synthesis Methodo…
- Founding Editor of the journal Research Synthesis Methods
- Chair of the Section on Health Policy Statistics at ASA
Similar researchers at Brown University
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Christopher Schmid
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup
